Amlodipine, Valsartan and Hydrochlorothiazide
- Product NDC
- 68180-772
- Requested package NDC
- 68180-772-09
- 11-digit product format
- 681800772
- Labeler code
- 68180
- Product ID
- 68180-772_5e938b33-b86d-40ab-b5c5-b7137ef9404d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amlodipine, Valsartan and Hydrochlorothiazide
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- ANDA200797
- Marketing category
- ANDA
- Marketing start
- 2015-06-04
- Substance
- AMLODIPINE BESYLATE; VALSARTAN; HYDROCHLOROTHIAZIDE
- Active strength
- 10; 160; 12.5 mg/1; mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 68180-772 | 68180-772-09 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A200797-001 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | EQ 5MG BASE;12.5MG;160MG | TABLET / ORAL | 2015-06-03 | ||
| A200797-002 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | EQ 5MG BASE;25MG;160MG | TABLET / ORAL | 2015-06-03 | ||
| A200797-003 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | EQ 10MG BASE;12.5MG;160MG | TABLET / ORAL | 2015-06-03 | ||
| A200797-004 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | EQ 10MG BASE;25MG;160MG | TABLET / ORAL | 2015-06-03 | ||
| A200797-005 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | EQ 10MG BASE;25MG;320MG | TABLET / ORAL | 2015-06-03 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A200797-001 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;12.5MG;160MG | TABLET / ORAL | 2015-06-03 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A200797-002 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;25MG;160MG | TABLET / ORAL | 2015-06-03 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A200797-003 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;12.5MG;160MG | TABLET / ORAL | 2015-06-03 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A200797-004 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;160MG | TABLET / ORAL | 2015-06-03 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A200797-005 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;320MG | TABLET / ORAL | 2015-06-03 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A200797-001 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;12.5MG;160MG | TABLET / ORAL | 2015-06-03 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A200797-002 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;25MG;160MG | TABLET / ORAL | 2015-06-03 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A200797-003 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;12.5MG;160MG | TABLET / ORAL | 2015-06-03 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A200797-004 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;160MG | TABLET / ORAL | 2015-06-03 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A200797-005 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;320MG | TABLET / ORAL | 2015-06-03 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A200797-001 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;12.5MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A200797-002 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;25MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A200797-003 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;12.5MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A200797-004 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A200797-005 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;320MG | TABLET / ORAL | AB | 2015-06-03 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200797-001 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;12.5MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200797-002 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;25MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200797-003 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;12.5MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200797-004 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200797-005 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;320MG | TABLET / ORAL | AB | 2015-06-03 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A200797-001 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;12.5MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A200797-002 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;25MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A200797-003 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;12.5MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A200797-004 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A200797-005 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;320MG | TABLET / ORAL | AB | 2015-06-03 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200797-001 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;12.5MG;160MG | TABLET / ORAL | AB | 2015-06-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200797-002 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;25MG;160MG | TABLET / ORAL | AB | 2015-06-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200797-003 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;12.5MG;160MG | TABLET / ORAL | AB | 2015-06-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200797-004 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;160MG | TABLET / ORAL | AB | 2015-06-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200797-005 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;320MG | TABLET / ORAL | AB | 2015-06-03 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200797-001 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;12.5MG;160MG | TABLET / ORAL | AB | 2015-06-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200797-002 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;25MG;160MG | TABLET / ORAL | AB | 2015-06-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200797-003 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;12.5MG;160MG | TABLET / ORAL | AB | 2015-06-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200797-004 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;160MG | TABLET / ORAL | AB | 2015-06-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200797-005 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;320MG | TABLET / ORAL | AB | 2015-06-03 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200797-001 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;12.5MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200797-002 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 5MG BASE;25MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200797-003 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;12.5MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200797-004 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;160MG | TABLET / ORAL | AB | 2015-06-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200797-005 | AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE | EQ 10MG BASE;25MG;320MG | TABLET / ORAL | AB | 2015-06-03 | 03ed91905a0d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A200797-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A200797-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A200797-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A200797-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A200797-005 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200797-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200797-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200797-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200797-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A200797-005 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A200797-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A200797-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A200797-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A200797-004 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A200797-005 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200797-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200797-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200797-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200797-004 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A200797-005 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200797-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200797-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200797-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200797-004 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A200797-005 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200797-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200797-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200797-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200797-004 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A200797-005 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200797-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200797-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200797-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200797-004 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A200797-005 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200797-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200797-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200797-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200797-004 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A200797-005 | AB | 1 | 5bbf6a4d5a75… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Amlodipine, Valsartan and Hydrochlorothiazide
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| AMLODIPINE BESYLATE | 10 mg/1 |
| VALSARTAN | 160 mg/1 |
| HYDROCHLOROTHIAZIDE | 12.5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 864V2Q084H | Internal UNII lookup |
| 80M03YXJ7I | Internal UNII lookup |
| 0J48LPH2TH | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68180-772-02 | Amlodipine, Valsartan and Hydrochlorothiazide | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 11 | |
| 68180-772-06 | Amlodipine, Valsartan and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 11 | |
| 68180-772-09 | Amlodipine, Valsartan and Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 11 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68180-772-06 | EA - Each | 68180-772 | aeac3f64-f320-4692-b828-1ed4c13983ea | 1 | 2015-07-20 |
| 68180-772-09 | EA - Each | 68180-772 | e2fdae36-310b-47ec-9539-b953c2ba8568 | 1 | 2015-07-20 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine, Valsartan and Hydrochlorothiazide | AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE | Lupin Pharmaceuticals, Inc. | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 2023-12-14 | Boxed warning, Warnings, Adverse reactions | 200797 ANDA200797 68180-772-09 68180-772 68180077209 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 848131 | amLODIPine 10 MG / valsartan 160 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet | PSN | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848151 | amLODIPine 10 MG / valsartan 160 MG / hydroCHLOROthiazide 25 MG Oral Tablet | PSN | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848135 | amLODIPine 10 MG / valsartan 320 MG / hydroCHLOROthiazide 25 MG Oral Tablet | PSN | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848140 | amLODIPine 5 MG / valsartan 160 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet | PSN | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848145 | amLODIPine 5 MG / valsartan 160 MG / hydroCHLOROthiazide 25 MG Oral Tablet | PSN | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848131 | amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet | SCD | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848151 | amlodipine 10 MG / hydrochlorothiazide 25 MG / valsartan 160 MG Oral Tablet | SCD | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848135 | amlodipine 10 MG / hydrochlorothiazide 25 MG / valsartan 320 MG Oral Tablet | SCD | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848140 | amlodipine 5 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet | SCD | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848145 | amlodipine 5 MG / hydrochlorothiazide 25 MG / valsartan 160 MG Oral Tablet | SCD | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848131 | amlodipine (as amlodipine besylate) 10 MG / HCTZ 12.5 MG / valsartan 160 MG Oral Tablet | SY | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848135 | amlodipine (as amlodipine besylate) 10 MG / HCTZ 25 MG / valsartan 320 MG Oral Tablet | SY | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848151 | amlodipine (as amlodipine besylate) 10 MG / hydrochlorothiazide 25 MG / valsartan 160 MG Oral Tablet | SY | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848140 | amlodipine (as amlodipine besylate) 5 MG / HCTZ 12.5 MG / valsartan 160 MG Oral Tablet | SY | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848145 | amlodipine (as amlodipine besylate) 5 MG / hydrochlorothiazide 25 MG / valsartan 160 MG Oral Tablet | SY | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848131 | amlodipine 10 MG / HCTZ 12.5 MG / valsartan 160 MG Oral Tablet | SY | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848151 | amlodipine 10 MG / HCTZ 25 MG / valsartan 160 MG Oral Tablet | SY | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848135 | amlodipine 10 MG / HCTZ 25 MG / valsartan 320 MG Oral Tablet | SY | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848140 | amlodipine 5 MG / HCTZ 12.5 MG / valsartan 160 MG Oral Tablet | SY | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
| 848145 | amlodipine 5 MG / HCTZ 25 MG / valsartan 160 MG Oral Tablet | SY | 5dbb43b1-3ea4-4fa5-a9aa-95d869ae65fe | 11 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 68180-772-09 | 68180077209 | 90 TABLET, FILM COATED in 1 BOTTLE (68180-772-09) | 2015-06-04 | 0000-00-00 | No | No | Current |